AI Biologist - Gene Therapy Discovery
LatchBio
Summary
Latch builds rigorous scientific benchmarks for AI agents across biology, working with frontier labs and pharma to measure whether agents can handle real biological workflows. We're seeking an AI Biologist to join our Gene Therapy Discovery team, pushing what AI can achieve in vector and payload design.
Job description
About the Role
You will be the scientific authority on ground truth, testing whether agents can reason like an expert gene therapy scientist. You will build the tasks and datasets behind our benchmarks across AAV, lentiviral, and non-viral delivery, from target tissue to candidate nomination.
Build the task
- Write gold-standard answers with the rationale an experienced vector scientist would defend.
- Design scenarios across the discovery arc: capsid or vector selection, promoter and regulatory element choice, payload design within packaging limits, transduction and expression, tropism, and early immunogenicity triage.
- Curate datasets from real programs: barcoded library NGS at DNA and RNA level, qPCR and ddPCR genome titers, capsid titers by ELISA or AUC, infectious unit assays, transduction across cell types and MOIs, payload expression, single-cell or spatial tropism, biodistribution, innate immune readouts.
- Build analysis pipelines in Python where useful, with tolerances that hold across replicates and analytical methods.
Set the hard calls
- Catch the artifact: variant enrichment from replication or packaging rather than transduction, DNA-level barcode recovery counting uptake rather than completed transduction, barcode frequency skew from GC content or PCR efficiency, empty-to-full ratio inconsistencies, partial genomes, transgene mRNA without protein.
- Adjudicate conflicts: in vitro transduction vs in vivo tropism, weak bulk expression vs tight tropism, DNA-level transduction deficit vs promoter silencing, pre-existing neutralizing antibodies vs intrinsic capsid performance, then name the experiment that settles it.
- Weigh the tradeoffs: tropism breadth vs specificity, expression level vs durability, payload size vs packaging capacity, promoter strength vs cell-type restriction, and when a potency gain costs immunogenicity or manufacturability.
Judge the agent
- Interrogate reasoning step by step and challenge conclusions that would not survive a project review.
- Pinpoint where agents go wrong: why the step fails, what an expert would do, what evidence would change the call.
- Score confidence, rewarding explicit uncertainty over overconfident calls on ambiguous data.
Requirements
- PhD in molecular biology, virology, genetics, bioengineering, or a related field; MS with equivalent hands-on program experience also qualifies
- 2 to 6 years hands-on in gene therapy at a biotech or pharma, with own analysis work in the last two years
- Personally generated or analyzed data that decided which vector, capsid, promoter, or payload advanced
- Direct experience with at least one of: capsid or vector engineering and library screening, promoter and regulatory element design, transduction and expression assays, tropism or biodistribution analysis, or vector immunogenicity
- Strong experimental design, quantitative analysis, and statistics
- Daily use of Claude, Cursor, or similar AI tools with judgment to spot unsound model reasoning
- Bonus: Python or R for own analyses
- Bonus: gene editing delivery or non-viral delivery (LNP, nanoparticle, electroporation)
Benefits
- Health, Dental & Vision Insurance
- 401(k)
- Paid Time Off
- Equity
- Company Outings
- Team Off-sites
Company overview
LatchBio is a San Francisco-based cloud platform that provides comprehensive data infrastructure and analysis tools for biotechnology research. Founded in 2021, the company offers a unified data platform designed to connect bench scientists, computational scientists, IT teams, and R&D leadership into a cohesive framework. Their platform enables scientists to store, transform, and visualize bioinformatics data, making data analysis faster, more accessible, and cost-effective. LatchBio's solution includes workflow orchestration, scalable cloud computing resources, data storage, and interactive visualization tools specifically tailored for biological data analysis. The company serves hundreds of biotech companies and research organizations, helping them accelerate R&D milestones by eliminating infrastructure complexities. With backing from prominent investors including Lux Capital and Coatue, LatchBio has raised significant funding to develop its platform that supports various omics technologies including NGS, spatial transcriptomics, and single-cell analysis.